70 related articles for article (PubMed ID: 27709546)
1. Development of a novel phantom for tau PET imaging.
Wagatsuma K; Miwa K; Yamao T; Kamitaka Y; Akamatsu G; Nakajima K; Miyaji N; Ishibashi K; Ishii K
Phys Med; 2024 Jun; 123():103399. PubMed ID: 38852366
[TBL] [Abstract][Full Text] [Related]
2. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
[TBL] [Abstract][Full Text] [Related]
3. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly.
Niimi Y; Janelidze S; Sato K; Tomita N; Tsukamoto T; Kato T; Yoshiyama K; Kowa H; Iwata A; Ihara R; Suzuki K; Kasuga K; Ikeuchi T; Ishii K; Ito K; Nakamura A; Senda M; Day TA; Burnham SC; Iaccarino L; Pontecorvo MJ; Hansson O; Iwatsubo T
Alzheimers Res Ther; 2024 May; 16(1):115. PubMed ID: 38778353
[TBL] [Abstract][Full Text] [Related]
4. Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET images.
Wagatsuma K; Sakata M; Miwa K; Hamano Y; Kawakami H; Kamitaka Y; Yamao T; Miyaji N; Ishibashi K; Tago T; Toyohara J; Ishii K
EJNMMI Phys; 2024 Apr; 11(1):37. PubMed ID: 38647924
[TBL] [Abstract][Full Text] [Related]
5. Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.
Ruwanpathirana GP; Williams RC; Masters CL; Rowe CC; Johnston LA; Davey CE
J Nucl Med; 2024 May; 65(5):781-787. PubMed ID: 38575189
[TBL] [Abstract][Full Text] [Related]
6. Inter-scanner Aβ-PET harmonization using barrel phantom spatial resolution matching.
Ruwanpathirana GP; Williams RC; Masters CL; Rowe CC; Johnston LA; Davey CE
Alzheimers Dement (Amst); 2024; 16(1):e12561. PubMed ID: 38476638
[TBL] [Abstract][Full Text] [Related]
7. Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan.
Shekari M; Verwer EE; Yaqub M; Daamen M; Buckley C; Frisoni GB; Visser PJ; Farrar G; Barkhof F; Gispert JD; Boellaard R;
EJNMMI Phys; 2023 Oct; 10(1):68. PubMed ID: 37906338
[TBL] [Abstract][Full Text] [Related]
8. Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study.
Wagatsuma K; Miwa K; Akamatsu G; Yamao T; Kamitaka Y; Sakurai M; Fujita N; Hanaoka K; Matsuda H; Ishii K
Ann Nucl Med; 2023 Sep; 37(9):494-503. PubMed ID: 37243882
[TBL] [Abstract][Full Text] [Related]
9. A review of harmonization strategies for quantitative PET.
Akamatsu G; Tsutsui Y; Daisaki H; Mitsumoto K; Baba S; Sasaki M
Ann Nucl Med; 2023 Feb; 37(2):71-88. PubMed ID: 36607466
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and efficacy of a tau PET tracer [
Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of amyloid PET using
Matsuda H; Okita K; Motoi Y; Mizuno T; Ikeda M; Sanjo N; Murakami K; Kambe T; Takayama T; Yamada K; Suehiro T; Matsunaga K; Yokota T; Tateishi U; Shigemoto Y; Kimura Y; Chiba E; Kawashima T; Tomo Y; Tachimori H; Kimura Y; Sato N
Ann Nucl Med; 2022 Dec; 36(12):1039-1049. PubMed ID: 36194355
[TBL] [Abstract][Full Text] [Related]
12. SimPET-An open online platform for the Monte Carlo simulation of realistic brain PET data. Validation for
Paredes-Pacheco J; López-González FJ; Silva-Rodríguez J; Efthimiou N; Niñerola-Baizán A; Ruibal Á; Roé-Vellvé N; Aguiar P
Med Phys; 2021 May; 48(5):2482-2493. PubMed ID: 33713354
[TBL] [Abstract][Full Text] [Related]
13. Harmonisation of PET/CT contrast recovery performance for brain studies.
Verwer EE; Golla SSV; Kaalep A; Lubberink M; van Velden FHP; Bettinardi V; Yaqub M; Sera T; Rijnsdorp S; Lammertsma AA; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2856-2870. PubMed ID: 33517517
[TBL] [Abstract][Full Text] [Related]
14. Reduction in amyloid β deposition on
Ogasawara K; Fujiwara S; Chida K; Terasaki K; Sasaki M; Kubo Y
Am J Nucl Med Mol Imaging; 2019; 9(6):316-320. PubMed ID: 31976161
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study.
Akamatsu G; Ikari Y; Ohnishi A; Matsumoto K; Nishida H; Yamamoto Y; Senda M;
EJNMMI Res; 2019 Sep; 9(1):91. PubMed ID: 31535240
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [
Kogan RV; de Jong BA; Renken RJ; Meles SK; van Snick PJH; Golla S; Rijnsdorp S; Perani D; Leenders KL; Boellaard R;
Alzheimers Dement (Amst); 2019 Dec; 11():472-482. PubMed ID: 31294076
[TBL] [Abstract][Full Text] [Related]
17. Quantitative applications in positron emission tomography achieved through signal modelling.
Al-Mashhadi RH; Tolbod LP
Am J Nucl Med Mol Imaging; 2019; 9(2):140-155. PubMed ID: 31139497
[TBL] [Abstract][Full Text] [Related]
18. Tissue volume and activity mapping using total intensity projection of PET/CT images.
Al-Mashhadi RH; Bentzon JF; Tolbod LP
Am J Nucl Med Mol Imaging; 2019; 9(1):1-11. PubMed ID: 30911433
[TBL] [Abstract][Full Text] [Related]
19. Phantom criteria for qualification of brain FDG and amyloid PET across different cameras.
Ikari Y; Akamatsu G; Nishio T; Ishii K; Ito K; Iwatsubo T; Senda M
EJNMMI Phys; 2016 Dec; 3(1):23. PubMed ID: 27709546
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
